Director of Qualigen Therapeutics, Inc. (NASDAQ:QLGN), Kruger Kurt H, buys 4,600 shares worth $15,925
According to Qualigen Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 23 09:11 PM, company Director, Kruger Kurt H disclosed buying 4,600 shares at a cost of $3.46. At the time of this transaction (Nov 23), this trade was worth $15,925 in total. As of Nov 23, Kruger Kurt H now owns 6,000 shares in total worth about $20,040.0.
For the last few recent trades made by Qualigen Therapeutics, Inc. (NASDAQ:QLGN) Director, Kruger Kurt H, we have the following information:
- SEC Form 4 filing: Nov 20: Bought 1,400 shares at the rate of $3.55 per share. Total worth of this trade was $4,969. Total number of shares owned as of Nov 20 were 1,400